Fisher & Paykel Healthcare share price on watch after guidance upgrade

The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price could be on the rise today after it upgraded its guidance for the full year…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price will be on watch today after it provided an update on its guidance for FY 2019.

a woman

What did Fisher & Paykel Healthcare announce?

This month there have been countless companies including Cochlear Limited (ASX: COH) and Flight Centre Travel Group Ltd (ASX: FLT) warning about the negative impacts the coronavirus outbreak is having on their businesses.

But one company that has experienced a surge in demand following the devastating outbreak of this virus is Fisher & Paykel Healthcare.

This morning it revealed that it has experienced better-than-expected sales in its Hospital product business following an increase in demand from China following the coronavirus outbreak.

Combined with higher than expected Homecare sales, this has led to the company upgrading its revenue and earnings guidance for the full year.

Guidance upgrade.

Management previously expected operating revenue to be approximately NZ$1.19 billion and net profit after tax to be approximately NZ$255 million to NZ$265 million for the 12 months ending March 31.

But this has now been lifted to revenue of approximately NZ$1.2 billion and net profit after tax in the range of approximately NZ$260 million to NZ$270 million.

Fisher & Paykel Healthcare's Managing Director and CEO, Lewis Gradon, explained: "We've seen better-than-expected sales in our Homecare product group combined with continued strong growth in our Hospital product group. This includes an increase in demand from China related to the COVID-19 coronavirus outbreak."

In addition to this, Mr Gradon advised that the company's supply chain should not be impacted greatly by the coronavirus as it does not have a manufacturing facility in China. And while some of its suppliers of raw materials are based in China, it doesn't expect any meaningful disruption.

Mr Gradon said: "At this stage, we do not anticipate any significant impact on supply to our existing customers. We will continue to assess this on an ongoing basis, particularly if the outbreak escalates or continues for a prolonged period."

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia owns shares of and has recommended Flight Centre Travel Group Limited. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Mid-aged couple looking at a laptop.
ASX Share Market News

5 things to watch on the ASX 200 on Friday

It could be a positive finish to the week for Aussie investors.

Read more »

Girl with make up and jewellery posing.
Broker Notes

After a big jump this week, what are brokers saying about the Lovisa share price?

Will the good times continue for this jewellery retailer?

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Looking for a 100% gain? One broker has a miner to watch

This rare earths company is building momentum.

Read more »

Three rock climbers hang precariously off a steep cliff face, each connected to the other with the higher person holding on and the two below them connected by their arms and rope but not making contact with the cliff face.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rather nasty Thursday session for investors.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Buy, hold, sell: Whitehaven, Endeavour, Neuren Pharmaceuticals shares

As earnings season continues, brokers have updated their ratings and 12-month price targets.

Read more »

Disappointed man with his hand to his forehead, looking at a falling share price on his laptop.
ASX Share Market News

Why is the ASX 200 falling to a 4-day low today?

What’s behind the market’s latest pullback?

Read more »

Woman smiles at camera at she buys greens from the supermarket.
Broker Notes

Do leading brokers rate Woolworths shares as a buy following its results?

Two leading brokers have given their take on the supermarket giant.

Read more »

Upset business woman in hijab working inside office,.
Broker Notes

7 ASX 200 shares downgraded by brokers this week

Brokers reduced their ratings on PLS Group, Lovisa, and others as earnings season continued.

Read more »